Complete Genomics Closes $39M Funding Round, Vows to 'Vigorously Defend' Against Illumina Suit

The new round brings Complete Genomics' total financing since inception to $130 million. The company closed the financing as it prepares for an initial public offering in which it aims to raise up to $86.25 million.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.